DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

Anastasopoulou, Eleftheria A; Tzonis, Panagiotis; Fortis, Sotirios P; Mahaira, Louisa; Vaxevanis, Christoforos; Ardavanis, Alexandros; Mittendorf, Elizabeth A; Peoples, George E; Baxevanis, Constantin N; Papamichail, Michael; Perez, Sonia A

doi:10.1186/2051-1426-3-S2-P427

Article metrics
Last updated: Fri, 19 Apr 2024 18:59:25 Z

DRB1*11 allele expression and HER2 pre-existing immunity may predict benefit in breast cancer patients vaccinated with the HER2 modified AE37 peptide vaccine

Access & Citations

803

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.